Fusion Pharmaceuticals Inc. (FUSN) Financials

FUSN Assets vs Liabilities

DateAssetsLiabilities
March 31, 2024 323.8 million 82.0 million
Dec. 31, 2023 285.8 million 63.4 million
Sept. 30, 2023 253.4 million 64.9 million
June 30, 2023 268.3 million 65.3 million

FUSN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -28.6 million 4.5 million
Dec. 31, 2023 -18.4 million 3.3 million
Sept. 30, 2023 -19.3 million 3.0 million
June 30, 2023 -20.3 million 3.0 million

FUSN Net Income

No data available :(

FUSN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 211.0 million 49.7 million 10.6 million
Dec. 31, 2023 234.1 million 34.8 million 11.4 million
Sept. 30, 2023 191.3 million 46.5 million 18.0 million
June 30, 2023 198.1 million 45.3 million 16.1 million

FUSN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 83.8 million
Dec. 31, 2023 73.1 million
Sept. 30, 2023 69.1 million
June 30, 2023 66.3 million

FUSN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 1.3 million 21.0 million 14.5 million -
Dec. 31, 2023 1.4 million 20.3 million 7.6 million -
Sept. 30, 2023 473000 14.6 million 6.8 million -
June 30, 2023 710000 19.0 million 7.8 million -

FUSN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 - 361000
Dec. 31, 2023 33.6 million 361000
Sept. 30, 2023 2.0 million 1.0 million
June 30, 2023 34000 931000

FUSN

Price: $21.55

52 week price:
2.31
21.58

Earnings Per Share: -1.40 USD

P/E Ratio: -6.94

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 14300

Market Capitalization: 1.8 billion

Links: